Physical health of people with severe mental disorders: leave no one behind

IF 60.5 1区 医学 Q1 PSYCHIATRY
World Psychiatry Pub Date : 2017-02-01 DOI:10.1002/wps.20403
S. Saxena, M. Maj
{"title":"Physical health of people with severe mental disorders: leave no one behind","authors":"S. Saxena, M. Maj","doi":"10.1002/wps.20403","DOIUrl":null,"url":null,"abstract":"The 2030 United Nations Agenda for Sustainable Development seeks to ensure that, over the next 15 years, countries make concerted efforts towards economic, social and environmental development that is sustainable and inclusive. In order to achieve the goal of universal health and well-being (Goal 3), an important target is “to reduce premature mortality from non-communicable diseases (NCD) through prevention and treatment and promote mental health and well-being”. While this goal applies to all, there is a need for making special efforts to the populations that are vulnerable to be left behind. One such population is people with severe mental disorders (SMD). SMD and NCD are related in complex ways. The major modifiable risk factors for NCD, such as physical inactivity, unhealthy diet, tobacco use and harmful use of alcohol, are exacerbated by poor mental health. Mental illness is a risk factor for NCDs; its presence increases the chance that an individual will also suffer from one or more chronic illnesses. In addition, individuals with mental health conditions are less likely to seek help for NCDs, and symptoms may affect adherence to treatment as well as prognosis. The physical health of people with SMD is commonly ignored not only by themselves and people around them, but also by health systems, resulting in crucial physical health disparities and limited access to health services. This impacts the life expectancy of people with SMD. The facts are clear: people with severe mental disorders die, on average, 15 to 20 years earlier than others. These excess and early deaths are not primarily due to suicide, but to physical diseases that occur more frequently, are not prevented adequately, are not identified early enough and are not treated effectively. And this disparity is not confined to some regions and countries, but seems to be a global reality. This state of affairs is not in keeping with the spirit and letter of the Sustainable Development Goals. It should be unacceptable to any country or community. What is needed? While interventions, guidelines and programmes have been developed to address the risk factors for excess mortality in persons with SMD, they will not really make a difference until a variety of challenges to their implementation are tackled, including problems with culture and attitudes of the various stakeholders involved, resources and expertise available, engagement of patients in the programmes, accessibility and feasibility of the interventions, their costeffectiveness, and the fidelity of their application. At the policy level, there is an obvious issue of prioritization. Reducing excess mortality in persons with SMD should become part of the broader health agenda. Top-level integration of various programmes (e.g., mental health and substance abuse, NCD, tobacco cessation, violence prevention, nutrition and physical exercise) should be set as a precedent for making strides in addressing complex, multifactorial health problems. Health programme managers should promote awareness of the problem amongst health care providers and equip them with training, support and supervision to deliver comprehensive care. Health care providers should be especially attuned not to overlook somatic concerns and to pay attention to the lifestyle behaviours of persons with SMD. At the very minimum, persons with SMD should have access to the same care offered to people with other health conditions, including the same basic health screenings as the general population (e.g., for cardiovascular risk and cancer). There are guidelines and tools available to assist general health care providers in the assessment and management of people with co-occurring physical and mental health conditions. An example of one such tool is the World Health Organization (WHO)’s mhGAP Intervention Guide for Mental and Neurological Disorders, the new version of which has been recently released. The Guide presents algorithms for clinical decision-making including specific guidelines for assessment and management of co-occurring physical health conditions. On the other hand, research challenges in this area should not be ignored. Among them are the problems of the representativeness of the study samples; of the availability and reliability of the information about the occurrence of mental disorders, the causes of death and the presence of the various risk and protective factors in the samples studied; and the difficulties in clarifying the relative impact of the various categories of risk and protective factors and the way these factors interact with each other. Furthermore, the evidence concerning protective factors is in general much more limited than that regarding risk factors, and high-quality research from low-income countries is still very scarce. The role of new communication technologies and of peer support in this field is also understudied. A major further challenge is the assessment of the impact of policy and health system interventions, which may emerge only after many years. Most importantly, the effectiveness and cost-effectiveness of evidence-based interventions and programmes will have to be evaluated systematically in different settings. Barriers to their implementation at various levels will have to be identified, and ways to address them appropriately tested. Also, the current focus on cardiometabolic risk in people with SMD living in the community should not distract our attention from the scandal of premature mortality among the mentally ill who live in large asylums, and the millions of people with SMD who are currently detained in prisons worldwide (see also McKenna et al in this issue of the journal), who are particularly exposed to chronic diseases (including, especially in low-income countries, infectious diseases), poor nutrition, victimization, neglect, suicide and substance abuse.","PeriodicalId":49357,"journal":{"name":"World Psychiatry","volume":" ","pages":""},"PeriodicalIF":60.5000,"publicationDate":"2017-02-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://sci-hub-pdf.com/10.1002/wps.20403","citationCount":"41","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"World Psychiatry","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.1002/wps.20403","RegionNum":1,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q1","JCRName":"PSYCHIATRY","Score":null,"Total":0}
引用次数: 41

Abstract

The 2030 United Nations Agenda for Sustainable Development seeks to ensure that, over the next 15 years, countries make concerted efforts towards economic, social and environmental development that is sustainable and inclusive. In order to achieve the goal of universal health and well-being (Goal 3), an important target is “to reduce premature mortality from non-communicable diseases (NCD) through prevention and treatment and promote mental health and well-being”. While this goal applies to all, there is a need for making special efforts to the populations that are vulnerable to be left behind. One such population is people with severe mental disorders (SMD). SMD and NCD are related in complex ways. The major modifiable risk factors for NCD, such as physical inactivity, unhealthy diet, tobacco use and harmful use of alcohol, are exacerbated by poor mental health. Mental illness is a risk factor for NCDs; its presence increases the chance that an individual will also suffer from one or more chronic illnesses. In addition, individuals with mental health conditions are less likely to seek help for NCDs, and symptoms may affect adherence to treatment as well as prognosis. The physical health of people with SMD is commonly ignored not only by themselves and people around them, but also by health systems, resulting in crucial physical health disparities and limited access to health services. This impacts the life expectancy of people with SMD. The facts are clear: people with severe mental disorders die, on average, 15 to 20 years earlier than others. These excess and early deaths are not primarily due to suicide, but to physical diseases that occur more frequently, are not prevented adequately, are not identified early enough and are not treated effectively. And this disparity is not confined to some regions and countries, but seems to be a global reality. This state of affairs is not in keeping with the spirit and letter of the Sustainable Development Goals. It should be unacceptable to any country or community. What is needed? While interventions, guidelines and programmes have been developed to address the risk factors for excess mortality in persons with SMD, they will not really make a difference until a variety of challenges to their implementation are tackled, including problems with culture and attitudes of the various stakeholders involved, resources and expertise available, engagement of patients in the programmes, accessibility and feasibility of the interventions, their costeffectiveness, and the fidelity of their application. At the policy level, there is an obvious issue of prioritization. Reducing excess mortality in persons with SMD should become part of the broader health agenda. Top-level integration of various programmes (e.g., mental health and substance abuse, NCD, tobacco cessation, violence prevention, nutrition and physical exercise) should be set as a precedent for making strides in addressing complex, multifactorial health problems. Health programme managers should promote awareness of the problem amongst health care providers and equip them with training, support and supervision to deliver comprehensive care. Health care providers should be especially attuned not to overlook somatic concerns and to pay attention to the lifestyle behaviours of persons with SMD. At the very minimum, persons with SMD should have access to the same care offered to people with other health conditions, including the same basic health screenings as the general population (e.g., for cardiovascular risk and cancer). There are guidelines and tools available to assist general health care providers in the assessment and management of people with co-occurring physical and mental health conditions. An example of one such tool is the World Health Organization (WHO)’s mhGAP Intervention Guide for Mental and Neurological Disorders, the new version of which has been recently released. The Guide presents algorithms for clinical decision-making including specific guidelines for assessment and management of co-occurring physical health conditions. On the other hand, research challenges in this area should not be ignored. Among them are the problems of the representativeness of the study samples; of the availability and reliability of the information about the occurrence of mental disorders, the causes of death and the presence of the various risk and protective factors in the samples studied; and the difficulties in clarifying the relative impact of the various categories of risk and protective factors and the way these factors interact with each other. Furthermore, the evidence concerning protective factors is in general much more limited than that regarding risk factors, and high-quality research from low-income countries is still very scarce. The role of new communication technologies and of peer support in this field is also understudied. A major further challenge is the assessment of the impact of policy and health system interventions, which may emerge only after many years. Most importantly, the effectiveness and cost-effectiveness of evidence-based interventions and programmes will have to be evaluated systematically in different settings. Barriers to their implementation at various levels will have to be identified, and ways to address them appropriately tested. Also, the current focus on cardiometabolic risk in people with SMD living in the community should not distract our attention from the scandal of premature mortality among the mentally ill who live in large asylums, and the millions of people with SMD who are currently detained in prisons worldwide (see also McKenna et al in this issue of the journal), who are particularly exposed to chronic diseases (including, especially in low-income countries, infectious diseases), poor nutrition, victimization, neglect, suicide and substance abuse.
严重精神障碍患者的身体健康:不让任何人掉队
《2030年联合国可持续发展议程》旨在确保各国在未来15年内共同努力,实现可持续和包容性的经济、社会和环境发展。为了实现全民健康和福祉的目标(目标3),一个重要目标是“通过预防和治疗降低非传染性疾病的过早死亡率,促进心理健康和福祉”。虽然这一目标适用于所有人,但有必要为易被落在后面的人口做出特别努力。其中一个群体是患有严重精神障碍(SMD)的人。SMD和NCD有着复杂的关系。非传染性疾病的主要可改变风险因素,如身体不活动、不健康饮食、吸烟和有害饮酒,因心理健康状况不佳而加剧。精神疾病是非传染性疾病的一个危险因素;它的存在增加了一个人患一种或多种慢性疾病的可能性。此外,有心理健康问题的人不太可能寻求非传染性疾病的帮助,症状可能会影响治疗的依从性和预后。SMD患者的身体健康通常不仅被他们自己和周围的人忽视,也被卫生系统忽视,导致严重的身体健康差距和获得卫生服务的机会有限。这会影响SMD患者的预期寿命。事实很清楚:患有严重精神障碍的人平均比其他人提前15到20年死亡。这些超额和早期死亡主要不是由于自杀,而是由于更频繁发生的身体疾病,没有得到充分预防,没有及早发现,也没有得到有效治疗。这种差距不仅限于某些地区和国家,而且似乎是全球现实。这种状况不符合可持续发展目标的精神和文字。任何国家或社区都不应接受这种做法。需要什么?虽然已经制定了干预措施、指导方针和方案来解决SMD患者死亡率过高的风险因素,但在解决实施这些干预措施的各种挑战之前,这些干预措施、准则和方案不会真正产生影响,包括各种利益攸关方的文化和态度问题、可用的资源和专业知识、,患者参与方案、干预措施的可及性和可行性、其成本效益以及应用的忠诚度。在政策层面,有一个明显的优先次序问题。降低SMD患者的超额死亡率应成为更广泛的卫生议程的一部分。应将各种方案(如心理健康和药物滥用、非传染性疾病、戒烟、预防暴力、营养和体育锻炼)的最高级别整合作为在解决复杂的多因素健康问题方面取得进展的先例。卫生方案管理人员应提高卫生保健提供者对这一问题的认识,并为他们提供培训、支持和监督,以提供全面的护理。卫生保健提供者应特别注意不要忽视身体问题,并注意SMD患者的生活方式行为。SMD患者至少应获得与其他健康状况患者相同的护理,包括与普通人群相同的基本健康筛查(例如心血管风险和癌症)。有可用的指导方针和工具可以帮助普通医疗保健提供者评估和管理同时存在身心健康状况的人。一个这样的工具的例子是世界卫生组织(世界卫生组织)的mhGAP精神和神经疾病干预指南,该指南的新版本最近已经发布。该指南介绍了临床决策的算法,包括评估和管理同时发生的身体健康状况的具体指南。另一方面,不应忽视这一领域的研究挑战。其中包括研究样本的代表性问题;关于精神障碍的发生、死亡原因以及所研究样本中存在的各种风险和保护因素的信息的可用性和可靠性;以及难以澄清各类风险和保护因素的相对影响以及这些因素之间相互作用的方式。此外,关于保护因素的证据通常比关于风险因素的证据要有限得多,来自低收入国家的高质量研究仍然非常稀缺。新的通信技术和同行支持在这一领域的作用也没有得到充分研究。 进一步的一个重大挑战是评估政策和卫生系统干预措施的影响,这可能在多年后才会出现。最重要的是,必须在不同的环境中系统地评估循证干预措施和方案的有效性和成本效益。必须确定在各个层面实施这些措施的障碍,并对解决这些障碍的方法进行适当的测试。此外,目前对生活在社区中的SMD患者心脏代谢风险的关注不应分散我们对生活在大型精神病院的精神病患者过早死亡的丑闻的注意力,以及目前被关押在世界各地监狱中的数百万SMD患者的注意力(另见本期杂志的McKenna等人),他们特别容易感染慢性病(特别是在低收入国家,包括传染病)、营养不良、受害、忽视、自杀和药物滥用。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 求助全文
来源期刊
World Psychiatry
World Psychiatry 医学-精神病学
自引率
7.40%
发文量
124
期刊介绍: World Psychiatry is the official journal of the World Psychiatric Association. It is published in three issues per year. The journal is sent free of charge to psychiatrists whose names and addresses are provided by WPA member societies and sections. World Psychiatry is also freely accessible on Wiley Online Library and PubMed Central. The main aim of World Psychiatry is to disseminate information on significant clinical, service, and research developments in the mental health field. The journal aims to use a language that can be understood by the majority of mental health professionals worldwide.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术官方微信